Parents who believe, or lean toward believing, false claims about the measles vaccine say they delayed or skipped some ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

Concerned that the nation’s health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

A former FDA commissioner and a former Institute of Medicine president are teaming up to create the Vaccine Integrity Project ...

CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Immunization has saved an estimated 150 million lives since 1974 — six lives every minute. Vaccination accounts for 40 ...

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.

Zostavax and Shingrix are linked to protection for older adults in multiple studies.